Impact of Repeated Doses of Subcutaneous Esketamine on Acute Dissociative Symptoms in Treatment-Resistant Depression

Background: Esketamine has been approved by the US Food and Drug Administration (FDA) as an adjunctive treatment for use in conjunction with an oral antidepressant for patients with treatment-resistant depression (TRD), but dissociative symptoms are common adverse effects. Methods: A retrospective a...

Full description

Saved in:
Bibliographic Details
Main Authors: Lorena Catarina Del Sant (Author), Luciana Maria Sarin (Author), Ana Cecília Lucchese (Author), Eduardo Jorge Muniz Magalhães (Author), Marco Aurélio Tuena (Author), Carolina Nakahira (Author), José Alberto Del Porto (Author), Acioly Luiz Tavares De Lacerda (Author), Jair de Jesus Mari (Author)
Format: Book
Published: MDPI AG, 2022-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

Internet

Connect to this object online.

3rd Floor Main Library

Holdings details from 3rd Floor Main Library
Call Number: A1234.567
Copy 1 Available